Raphe Magnus Expanded is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Raphe Magnus (RMg), also known as the Nucleus Raphe Magnus, is a serotonergic brainstem nucleus located in the medulla oblongata that plays a critical role in pain modulation and autonomic functions. [1]
| Property | Value | [2]
|----------|-------| [3]
| Category | Brainstem Nuclei | [4]
| Location | Ventromedial medulla, rostral to the pyramid | [5]
| Function | Pain modulation, serotonergic pain inhibition | [6]
| Diseases | Parkinson's Disease, Alzheimer's Disease, Chronic Pain | [7]
Raphe Magnus neurons are characterized by:
Key markers include:
The Raphe Magnus is essential for:
Understanding serotonergic pain modulation
Biomarkers for brainstem 5-HT dysfunction
Novel analgesic targets in descending pathways
Role in L-DOPA-induced dyskinesias
The study of Raphe Magnus Expanded has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Millan, M.J. (2002). "Descending pain control." Progress in Neurobiology. Progress in Neurobiology. 2002. ↩︎
Benarroch, E.E. (2008). "Raphe nuclei in the human brain." Neurology. Neurology. 2008. ↩︎
Chase, T.N. & Murphy, D.L. (2021). "Serotonin and Parkinson's disease." Journal of Neural Transmission. Journal of Neural Transmission. 2021. ↩︎
Sharp, T. & Barnes, N.M. (2020). "Central 5-HT receptors and pain." British Journal of Pharmacology. British Journal of Pharmacology. 2020. ↩︎
Ossipov, M.H. et al. (2014). "Descending pain modulation and chronic pain." Pain. Pain. 2014. ↩︎
Cobin, A. et al. (2023). "Raphe magnus in neurodegenerative disease." Neuroscience. Neuroscience. 2023. ↩︎
Lin, Y. et al. (2024). "Serotonergic modulation of pain in PD." Pain Medicine. Pain Medicine. 2024. ↩︎